Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP433970.RA-hi9EabYhY0To1cyQXahP_Vy1Av2djgfCE9DY_TZHNQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP433970.RA-hi9EabYhY0To1cyQXahP_Vy1Av2djgfCE9DY_TZHNQ130_assertion type Assertion NP433970.RA-hi9EabYhY0To1cyQXahP_Vy1Av2djgfCE9DY_TZHNQ130_head.
- NP433970.RA-hi9EabYhY0To1cyQXahP_Vy1Av2djgfCE9DY_TZHNQ130_assertion description "[Granulin-epithelin precursor (GEP) has previously been reported to control cancer growth, invasion, chemo-resistance, and served as novel therapeutic target for cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433970.RA-hi9EabYhY0To1cyQXahP_Vy1Av2djgfCE9DY_TZHNQ130_provenance.
- NP433970.RA-hi9EabYhY0To1cyQXahP_Vy1Av2djgfCE9DY_TZHNQ130_assertion evidence source_evidence_literature NP433970.RA-hi9EabYhY0To1cyQXahP_Vy1Av2djgfCE9DY_TZHNQ130_provenance.
- NP433970.RA-hi9EabYhY0To1cyQXahP_Vy1Av2djgfCE9DY_TZHNQ130_assertion SIO_000772 22792281 NP433970.RA-hi9EabYhY0To1cyQXahP_Vy1Av2djgfCE9DY_TZHNQ130_provenance.
- NP433970.RA-hi9EabYhY0To1cyQXahP_Vy1Av2djgfCE9DY_TZHNQ130_assertion wasDerivedFrom befree-20150227 NP433970.RA-hi9EabYhY0To1cyQXahP_Vy1Av2djgfCE9DY_TZHNQ130_provenance.
- NP433970.RA-hi9EabYhY0To1cyQXahP_Vy1Av2djgfCE9DY_TZHNQ130_assertion wasGeneratedBy ECO_0000203 NP433970.RA-hi9EabYhY0To1cyQXahP_Vy1Av2djgfCE9DY_TZHNQ130_provenance.